50-35-1;731-40-8 thalidomide
| ürün Ad? |
thalidomide |
| ingilizce ad? |
thalidomide; 2-phthalimidoglutarimide; 2-(2,6-dioxo-3-piperidinyl)-1h-isoindole-1,3(2h)-dione; 2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione |
| Moleküler Formülü |
C13H10N2O4 |
| Molekül A??rl??? |
258.2295 |
| InChI |
InChI=1/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17) |
| CAS kay?t numaras? |
50-35-1;731-40-8 |
| EINECS |
200-031-1 |
| Moleküler Yap?s? |
|
| Yo?unluk |
1.503g/cm3 |
| Ergime noktas? |
269-271℃ |
| Kaynama noktas? |
509.7°C at 760 mmHg |
| K?r?lma indisi |
1.646 |
| Alevlenme noktas? |
262.1°C |
| Suda ??zünürlük |
<0.1 g/100 mL at 22℃ |
| Buhar bas?nc? |
1.65E-10mmHg at 25°C |
| Tehlike Sembolleri |
T:Toxic;
|
| Risk Kodlar? |
R46:;
R61:;
R21:;
R25:;
R62:;
|
| Güvenlik A??klamas? |
S53:;
S22:;
S26:;
S36/37/39:;
S45:;
|
|